Scene innovation empower the construction of the urban demonstration area of the park ③ | The cell industry enters the rapid development period Chengdu.

At present, life science has become an active field of cutting -edge scientific research, and biotechnology has become an effective force for promoting future development. In recent years, the country and local level have introduced relevant policies to support the development of biotechnology, biological industry, and biological economy. As an important part of biotechnology, the cell technology has become increasingly active under the blessing of policy dividends and accelerated results, and the cell industry has also entered a period of rapid development.

As a new economic enterprise focusing on the R & D, storage, preparation and application of cell technology, Chengdu Kangjing Biotechnology Co., Ltd. (hereinafter referred to as "Kangjing Bio") is taking off in such a big background. The first to deploy the entire industry chain business. Earlier, the company has been awarded national high -tech enterprises, national science and technology SMEs, and the first batch of high -tech enterprises in the cell industry in Sichuan Province. Its personalized preparation scenarios invested and constructed were also selected as a demonstration of the "100 Thousands of Thousands" scene in Chengdu City. The first batch of demonstration application scenarios supported by engineering projects.

(Chengdu Regional Cell Preparation Center)

Self -built cell preparation center, cell library

The first to deploy the entire industry chain

"As one of the cutting -edge biomedical technology, cell technology plays a positive role in disease prevention, disease treatment, health promotion, etc., and protects people's life and health." Kang Jing Biological Vice Chairman and General Manager Kou Dalian said that cellular technology Application has entered people's lives.

"Innovation leads the future, innovate the future, and innovate the future. We always focus on patient needs, guided clinical value, and focus on the research and development of biological cell innovation drugs for the treatment of rare and refractory diseases." Kou Dalian Lianlian According to the introduction of Kangjing Bio, in 2013, after nine years of development, in -depth cooperative relationships have been established with well -known institutions such as the Institute of Blood Invasion of the Chinese Academy of Medical Sciences, the Huaxi Hospital of Sichuan University, and the Xinqiao Hospital of the Army Military Medical University. With the effort, many R & D results have been achieved.

In 2018, under the guidance of relevant government departments, Kangjing Bio established the "Chengdu (Kangjing) Regional Cell Preparation Center" and "Chengdu Comprehensive Cell Library", which realized the "automated production", "large -scale preparation", "individuality" The ordering "and" clinical applications "are the first to establish a business system covering upstream storage, midstream preparation, and downstream applications covering the cell industry, becoming the first cell technology enterprise in Sichuan Province to deploy the entire industry chain.

Establish a personalized preparation scenario of biological cells

Promote the popular science and value conversion of cell culture

"Although cellular technology has a wide range of uses, ordinary people know very little about cell technology. Therefore, in order to promote the popular science and value conversion of cell culture, we have established a personalized preparation scenario of biological cells." Kou Dalian said that the scene was by cell culture The exhibition hall and the regional preparation center exhibition hall are composed of the exhibition hall, which respectively undertake the process display of cultural science and cell preparation of cell origin and application. It is one of the demonstration application scenarios supported by the "100 Thousand Thousand" scene demonstration project in 2020.

The cell culture exhibition hall is deployed according to the human life cycle, and is divided into several chapters of "birth -growth -recession -regeneration", which vividly interprets the role of cells in the life of human beings. The exhibition hall is also equipped with a professional interpreter reception visitor. It is both vivid and easy to understand and have the explanations of cutting -edge academic technology dynamics, and play a role in carrying out the basic science popularization of cells to the public, which is of positive significance for promoting the development of the cell industry.

(Cell Culture Exhibition Hall)

"As a carrier of corporate culture, the exhibition hall still allows the public to understand our window." Kou Dalian introduced that the exhibition hall was equipped with a warm and comfortable negotiation room, a high -function influence hall, and a functional conference room that accommodates hundreds of people. A certain market value.

Welcome to new opportunities for development

Depending on becoming the leader of the cell industry

Biological economy is based on the sustainable use of biological resources and biotechnology, and is based on the production, distribution and use of biotechnology products. The biological economy has green and regenerative characteristics. It is the most active emerging economic form of the 21st century. It is also the main direction of my country's strategic emerging industries. Vigorously developing the biological economy is of great significance for Chengdu to accelerate the construction of a green and low -carbon circular economy system and cultivate new economic growth points.

At the end of last year, the National Development and Reform Commission issued the "Fourteenth Five -Year Plan" Biological Economic Development Plan, which mentioned that it is necessary to accelerate the improvement of biotechnology innovation capabilities, develop new technologies such as stem cell therapy, immune cell therapy, and strengthen cooperative linkage of industry, university, research The development of healthy industries, developing advanced technologies such as cell preparation automation, and promoting the development of biopharmaceuticals such as antibody drugs, recombinant proteins, polypeptides, cells and gene therapy products.

Earlier this year, nine departments such as the Ministry of Industry and Information Technology jointly released the "Fourteenth Five -Year Plan" pharmaceutical industry development plan ". It also mentioned that the new generation of biotechnology represented by cell therapy and gene therapy is becoming increasingly mature to grab a new round of grabbing the pharmaceutical industry. The scientific and technological revolution and industrial changes have provided broad space.

A series of deployments such as the "Fourteenth Five -Year Plan" plan not only indicate that the status of the biological economy has continued to rise, but its development direction is becoming more clear. Focusing on Chengdu, the leadership of biotechnology levels in the west, outstanding development advantages in the biological industry, continuous optimization of biological economic development ecology, and effective control of biological safety risks, and a good foundation for developing the biological economy.

In May this year, the "14th Five -Year Plan of Chengdu" Biological Economic Development Plan "was released. The qualitative goal of the "Planning" proposes that by 2025, the biological industry cluster with global competitiveness and influence will be basically built, and the ecological environment and biological safety risk prevention and governance system that adapts to the development of biological economic development; By 2035, the role of the nationwide biological economic pilot zone will be further prominent, and it will build a new highland with international competitive biological economy. Focusing on qualitative goals, the quantitative goal of "Planning" proposed that the annual growth rate of biological economy during the "Fourteenth Five-Year Plan" period will remain at about 15%. By 2025, the total output value of the biological economy will reach 1.2 trillion yuan, and 3-5 national levels will be created. Biotechnology innovation platforms have 3-5 professional databases in the field of biological economy, and the size of the biological economic associated industrial fund has reached more than 50 billion yuan. It is worth noting that "Planning" incorporates key technologies such as cell therapy and immunotherapy and other forward -looking biological therapy into key areas of targeted breakthroughs in key areas. From the country to the local area, the support policy is densely introduced. Under the blessing of policy dividends, cell technology companies represented by Kangjing Bio ushered in a new period of development opportunities.

"We are determined to be the leader of the cell industry." Kou Dalian said that in the future, Kangjing creatures will be as always focusing on the research and development of cell technology, carrying out cell storage, preparation and application, striving to transform more results, and serve more people.

Chengdu Daily Jinguan News Reporter Li Yanling Editor He Qixie Editor Liu Yonghao Picture Interviewing Enterprise

- END -